박병탁 기자

Park Pyeongtak

Reporter
Biowatch Team With a background in Business Administration (MBA), I focus on the pharmaceutical and biotech industries. My goal is to select key information and present it in an easily understandable manner.
mail ppt@kormedi.com

Latest Articles

Kyungdong Pharmaceutical and AUL Bio Seek Phase 1 Approval for Once-Monthly Obesity Drug AUL009

South Korea’s First Homegrown CAR-T, Rimqarto, Moves Closer to Coverage with 67% Complete Response Rate

SK Plasma Launches High-Dose Revolpag 75 mg to Simplify Thrombocytopenia Regimens and Cut Costs

JW Pharmaceutical Expands 'Frenz' Brand Beyond Eye Drops with Launch of 'Eye Crunch' Candy

Zymfentra U.S. Sales Surge 176% as Celltrion’s Remsima Franchise Eyes 1 Trillion Won Annual Revenue

Chong Kun Dang Expands 'Modcol' Cold Medicine Lineup with Acetaminophen and Ibuprofen Options

Celltrion Files for South Korean Approval of Keytruda Biosimilar CT-P51

Samyang Biopharm’s NanoReady Delivers 20x mRNA Payload for Personalized Cancer Vaccines

Previous1234Next